Y-mAbs Therapeutics, Inc (NASDAQ:YMAB)

32.97
Delayed Data
As of Jan 17
 +0.35 / +1.07%
Today’s Change
18.60
Today|||52-Week Range
34.49
+5.50%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$1.3B

Company Description

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It develops novel antibody therapeutics for oncology targets. The company's services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.

Contact Information

Y-mAbs Therapeutics, Inc.
230 Park Avenue
New York New York 10169
P:(646) 885-8505
Investor Relations:

Employees

Shareholders

Individual stakeholders28.99%
Mutual fund holders26.12%
Other institutional2.14%

Top Executives

There are no executives to display.